Literature DB >> 9427967

Monofilament intraluminal middle cerebral artery occlusion in the mouse.

W M Clark1, N S Lessov, M P Dixon, F Eckenstein.   

Abstract

The rat middle cerebral artery (MCA) occlusion model with an intraluminal filament is well characterized with a two hour period of occlusion in widespread use. The recent availability of transgenic animals has led to an interest in adapting the MCA model in the mouse. To date the model has not been well characterized in the mouse. We performed the present study to compare different durations of MCA occlusion and to validate new functional assessments in this model. The MCA occlusion model (5-0 filament) was used. Swiss-Webster mice, 24-44 g, were randomly assigned to four groups: one hour of occlusion; two hours of occlusion; three hours of occlusion; or permanent occlusion. At 48 hours post-ischemia, the animals were rated on three neurologic function scales, and then the brains were removed for lesion size determination. Overall, there was a significant difference in lesion volume (p < 0.001) between the groups. In the permanent group of mice, the average lesion volume was 78.41 +/- 17.47 mm (n = 12); two and three hours of ischemia produced 51.29 +/- 29.82 mm3 (n = 11) and 54.85 mm3 (n = 13), respectively, significantly different than the one hour group 14.84 +/- 31.34 mm3 (n = 11). All three functional scoring systems found significant overall differences between the four groups with our detailed General and Focal scores producing more robust between group treatment differences and showing correlation coefficients of r = 0.766 and r = 0.788, respectively to infarct volume. The MCA filament occlusion model can be successfully adapted in the mouse with either two or three hour occlusions producing reliable infarcts. New functional scoring systems unique to the mouse appear to add additional information.

Entities:  

Mesh:

Year:  1997        PMID: 9427967     DOI: 10.1080/01616412.1997.11740874

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  97 in total

1.  Toll-like receptor 7 preconditioning induces robust neuroprotection against stroke by a novel type I interferon-mediated mechanism.

Authors:  Philberta Y Leung; Susan L Stevens; Amy E B Packard; Nikola S Lessov; Tao Yang; Valerie K Conrad; Noortje N A M van den Dungen; Roger P Simon; Mary P Stenzel-Poore
Journal:  Stroke       Date:  2012-03-08       Impact factor: 7.914

2.  Neuronal expression of the mitochondrial protein prohibitin confers profound neuroprotection in a mouse model of focal cerebral ischemia.

Authors:  Anja Kahl; Corey J Anderson; Liping Qian; Henning Voss; Giovanni Manfredi; Costantino Iadecola; Ping Zhou
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-17       Impact factor: 6.200

3.  Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor.

Authors:  Omar Touzani; Herve Boutin; Rosalind LeFeuvre; Lisa Parker; Andy Miller; Giamal Luheshi; Nancy Rothwell
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

4.  MicroRNA-103-1 selectively downregulates brain NCX1 and its inhibition by anti-miRNA ameliorates stroke damage and neurological deficits.

Authors:  Antonio Vinciguerra; Luigi Formisano; Pierpaolo Cerullo; Natascia Guida; Ornella Cuomo; Alba Esposito; Gianfranco Di Renzo; Lucio Annunziato; Giuseppe Pignataro
Journal:  Mol Ther       Date:  2014-06-23       Impact factor: 11.454

5.  Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon/neuron loss and improves neurological function after stroke.

Authors:  Nsikan Akpan; Esther Serrano-Saiz; Brad E Zacharia; Marc L Otten; Andrew F Ducruet; Scott J Snipas; Wen Liu; Jennifer Velloza; Greg Cohen; Sergeyi A Sosunov; William H Frey; Guy S Salvesen; E Sander Connolly; Carol M Troy
Journal:  J Neurosci       Date:  2011-06-15       Impact factor: 6.167

6.  A Mouse Brain-based Multi-omics Integrative Approach Reveals Potential Blood Biomarkers for Ischemic Stroke.

Authors:  Alba Simats; Laura Ramiro; Teresa García-Berrocoso; Ferran Briansó; Ricardo Gonzalo; Luna Martín; Anna Sabé; Natalia Gill; Anna Penalba; Nuria Colomé; Alex Sánchez; Francesc Canals; Alejandro Bustamante; Anna Rosell; Joan Montaner
Journal:  Mol Cell Proteomics       Date:  2020-08-31       Impact factor: 5.911

7.  Gene inactivation of Na+/H+ exchanger isoform 1 attenuates apoptosis and mitochondrial damage following transient focal cerebral ischemia.

Authors:  Yanping Wang; Jing Luo; Xinzhi Chen; Hai Chen; Sam W Cramer; Dandan Sun
Journal:  Eur J Neurosci       Date:  2008-07       Impact factor: 3.386

8.  Rodent models of focal cerebral ischemia: procedural pitfalls and translational problems.

Authors:  Stefan Braeuninger; Christoph Kleinschnitz
Journal:  Exp Transl Stroke Med       Date:  2009-11-25

9.  Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke.

Authors:  Alvaro Cervera; Anna M Planas; Carles Justicia; Xabier Urra; Jens C Jensenius; Ferran Torres; Francisco Lozano; Angel Chamorro
Journal:  PLoS One       Date:  2010-02-03       Impact factor: 3.240

Review 10.  Neurological and neurobehavioral assessment of experimental subarachnoid hemorrhage.

Authors:  Hyojin Jeon; Jinglu Ai; Mohamed Sabri; Asma Tariq; Xueyuan Shang; Gang Chen; R Loch Macdonald
Journal:  BMC Neurosci       Date:  2009-08-25       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.